Knut T. Smerud

Oslo, 0274, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

A Phase II Study of 177Lu-Lilotomab Satetraxetan, a CD37 Antibody-Radionuclide Conjugate, as Third- or Later-Line Treatment of Rituximab-Refractory Follicular B-Cell Lymphoma Patients.

A Phase II Study of 177Lu-Lilotomab Satetraxetan, a CD37 Antibody-Radionuclide Conjugate, as Third- or Later-Line Treatment of Rituximab-Refractory Follicular B-Cell Lymphoma Patients.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 01, 2025

Phase I, open-label, multi-center dose-finding and expansion study to investigate the safety, tolerability, and preliminary efficacy of CR-001 (5-FU-miR-15a) in patients with acute myeloid leukemia.

Phase I, open-label, multi-center dose-finding and expansion study to investigate the safety, tolerability, and preliminary efficacy of CR-001 (5-FU-miR-15a) in patients with acute myeloid leukemia.

Journal: Leukemia

Published: October 27, 2025

Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data.

Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data.

Journal: The lancet. Psychiatry

Published: November 29, 2024

Hip geometry and strength remain stable the first year after kidney transplantation-an ibandronate/placebo post hoc analysis.

Hip geometry and strength remain stable the first year after kidney transplantation-an ibandronate/placebo post hoc analysis.

Journal: JBMR plus

Published: August 23, 2024

Trabecular Bone Score Improves Early After Successful Kidney Transplantation Irrespective of Antiresorptive Therapy and Changes in Bone Mineral Density.

Trabecular Bone Score Improves Early After Successful Kidney Transplantation Irrespective of Antiresorptive Therapy and Changes in Bone Mineral Density.

Journal: Transplantation direct

Published: October 02, 2023

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial.

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial.

Journal: Kidney medicine

Published: January 03, 2023

Astatine-211 based radionuclide therapy: Current clinical trial landscape.

Astatine-211 based radionuclide therapy: Current clinical trial landscape.

Journal: Frontiers in medicine

Published: October 21, 2022

Evaluating the alginate oligosaccharide (OligoG) as a therapy for Burkholderia cepacia complex cystic fibrosis lung infection.

Evaluating the alginate oligosaccharide (OligoG) as a therapy for Burkholderia cepacia complex cystic fibrosis lung infection.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 30, 2021

Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study.

Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study.

Journal: ERJ open research

Published: March 18, 2020

Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives.

Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives.

Journal: Therapeutic delivery

Published: June 27, 2018

Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men.

Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men.

Journal: Hormones and behavior

Published: April 05, 2018

Low-dose intranasal oxytocin delivered with Breath Powered device modulates pupil diameter and amygdala activity: a randomized controlled pupillometry and fMRI study.

Low-dose intranasal oxytocin delivered with Breath Powered device modulates pupil diameter and amygdala activity: a randomized controlled pupillometry and fMRI study.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: March 22, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026